B. A. C. Dijkmans

2.6k total citations · 1 hit paper
24 papers, 1.9k citations indexed

About

B. A. C. Dijkmans is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, B. A. C. Dijkmans has authored 24 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 4 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Hematology. Recurrent topics in B. A. C. Dijkmans's work include Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (7 papers) and Spondyloarthritis Studies and Treatments (5 papers). B. A. C. Dijkmans is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (7 papers) and Spondyloarthritis Studies and Treatments (5 papers). B. A. C. Dijkmans collaborates with scholars based in Netherlands, United Kingdom and Norway. B. A. C. Dijkmans's co-authors include Michael T. Nurmohamed, Tore K Kvien, Naveed Sattar, Iain B. McInnes, Sella Aarrestad Provan, George D. Kitas, Yvo M. Smulders, David McCarey, Zoltán Szekanecz and Anne Grete Semb and has published in prestigious journals such as Annals of the Rheumatic Diseases, Osteoporosis International and Lara D. Veeken.

In The Last Decade

B. A. C. Dijkmans

24 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

2009 969 citations M.J. Peters, Deborah Symmons et al. Annals of the Rheumatic Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. A. C. Dijkmans Netherlands	13	1.5k	394	320	312	238	24	1.9k
Tracey E. Toms United Kingdom	23	1.0k 0.7×	247 0.6×	381 1.2×	230 0.7×	76 0.3×	33	1.5k
Beverley Harrison United Kingdom	20	1.5k 1.0×	397 1.0×	95 0.3×	479 1.5×	191 0.8×	29	1.9k
Vokko P. van Halm Netherlands	15	1.2k 0.8×	276 0.7×	370 1.2×	160 0.5×	70 0.3×	42	1.6k
P.L. van Riel Netherlands	15	2.1k 1.4×	349 0.9×	179 0.6×	742 2.4×	130 0.5×	34	2.5k
George Karpouzas United States	19	895 0.6×	442 1.1×	231 0.7×	133 0.4×	128 0.5×	67	1.3k
Lotta Ljung Sweden	15	937 0.6×	255 0.6×	192 0.6×	315 1.0×	72 0.3×	43	1.3k
M Haga Canada	8	1.2k 0.8×	255 0.6×	119 0.4×	277 0.9×	114 0.5×	10	1.6k
Arturo Rodríguez de la Serna Spain	15	630 0.4×	224 0.6×	224 0.7×	171 0.5×	93 0.4×	35	1.2k
Ingrid Avalos United States	18	1.0k 0.7×	443 1.1×	318 1.0×	93 0.3×	95 0.4×	22	1.5k
Yu Asanuma Japan	14	1.0k 0.7×	837 2.1×	278 0.9×	201 0.6×	101 0.4×	48	1.6k

Countries citing papers authored by B. A. C. Dijkmans

Since Specialization

Citations

This map shows the geographic impact of B. A. C. Dijkmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. A. C. Dijkmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. A. C. Dijkmans more than expected).

Fields of papers citing papers by B. A. C. Dijkmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. A. C. Dijkmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. A. C. Dijkmans. The network helps show where B. A. C. Dijkmans may publish in the future.

Co-authorship network of co-authors of B. A. C. Dijkmans

This figure shows the co-authorship network connecting the top 25 collaborators of B. A. C. Dijkmans. A scholar is included among the top collaborators of B. A. C. Dijkmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. A. C. Dijkmans. B. A. C. Dijkmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horst‐Bruinsma, Irene van der, Stefan Bruijnen, Pierre M. Bet, et al.. (2012). AB0889 Low percentage of MRI changes in clinically suspected axial spondyloarthritis. Annals of the Rheumatic Diseases. 71. 689–689. 1 indexed citations

Woude, Diane van der, Naomi B. Klarenbeek, H. K. Ronday, et al.. (2012). Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies. Lara D. Veeken. 51(6). 1120–1128. 32 indexed citations

Vis, Marijn, Espen A. Haavardsholm, Pernille Bøyesen, et al.. (2011). High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis. Osteoporosis International. 22(9). 2413–2419. 53 indexed citations

Broek, Maries van den, et al.. (2011). The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study. Annals of the Rheumatic Diseases. 71(2). 245–248. 72 indexed citations

Klarenbeek, Naomi B., Melek Güler-Yüksel, M. van Oosterhout, et al.. (2011). Simplified versions of the original disease activity score: validation in the BeSt trial. Annals of the Rheumatic Diseases. 70(8). 1471–1474. 9 indexed citations

Stadt, Lotte A van de, A. R. van der Horst, Margret H. M. T. De Koning, et al.. (2010). The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia. Annals of the Rheumatic Diseases. 70(1). 128–133. 137 indexed citations

Klarenbeek, Naomi B., S M van der Kooij, T. Huizinga, et al.. (2010). Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial. Annals of the Rheumatic Diseases. 69(7). 1342–1345. 51 indexed citations

Bos, Wouter H, Gertjan Wolbink, Maarten Boers, et al.. (2009). Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Annals of the Rheumatic Diseases. 69(3). 490–494. 208 indexed citations

Peters, Matthew, Lois M. Cherry, Paul Welsh, et al.. (2009). Lack of effect of TNFα blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies. Annals of the Rheumatic Diseases. 69(9). 1687–1690. 31 indexed citations

10.

Weely, Salima van, Irene van der Horst‐Bruinsma, Michael T. Nurmohamed, et al.. (2009). Reproducibility of performance measures of physical function based on the BASFI, in ankylosing spondylitis. Lara D. Veeken. 48(10). 1254–1260. 29 indexed citations

11.

Peters, M.J., Deborah Symmons, David McCarey, et al.. (2009). EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Annals of the Rheumatic Diseases. 69(2). 325–331. 969 indexed citations breakdown →

12.

Vries‐Bouwstra, Jeska K de, Y P M Goekoop-Ruiterman, K. N. Verpoort, et al.. (2008). Progression of joint damage in early rheumatoid arthritis: Association with HLA–DRB1, rheumatoid factor, and anti–citrullinated protein antibodies in relation to different treatment strategies. Arthritis & Rheumatism. 58(5). 1293–1298. 86 indexed citations

13.

Güler-Yüksel, Melek, J. Bijsterbosch, Y P M Goekoop-Ruiterman, et al.. (2007). Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis. Annals of the Rheumatic Diseases. 66(11). 1508–1512. 54 indexed citations

14.

Swaneveld, Francis, Richard M. van Vugt, Jan Paul de Boer, B. A. C. Dijkmans, & Willem F. Lems. (2007). A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma. Clinical Rheumatology. 27(2). 249–251. 1 indexed citations

15.

Wijbrandts, C A, M.G.W. Dijkgraaf, Maarten C. Kraan, et al.. (2007). The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor Î± expression in the synovium. Annals of the Rheumatic Diseases. 67(8). 1139–1144. 113 indexed citations

16.

Voskuyl, Alexandre E. & B. A. C. Dijkmans. (2007). Remission and radiographic progression in rheumatoid arthritis.. PubMed. 24(6 Suppl 43). S–37. 11 indexed citations

17.

Dijkmans, B. A. C., et al.. (2002). Combination Treatment in Autoimmune Diseases. 1 indexed citations

18.

Landewé, R. B. M., J. M. W. Hazes, Jan P. Vandenbroucke, et al.. (1998). No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis. Arthritis & Rheumatism. 41(11). 1930–1937. 3 indexed citations

19.

Speyer, I., F C Breedveld, & B. A. C. Dijkmans. (1998). Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients.. PubMed. 16(5). 576–8. 36 indexed citations

20.

Janssen, M., B. A. C. Dijkmans, Jan P. Vandenbroucke, I. Biemond, & C. B. H. W. Lamers. (1993). THE FREQUENCY OF EXTREMELY LOW SERUM PEPSINOGEN, INDICATIVE OF CORPUS GASTRITIS WITH SEVERE ATROPHY, IN RHEUMATOID ARTHRITIS, OTHER CHRONIC RHEUMATIC DISEASES AND NON-RHEUMATIC DISEASES. Lara D. Veeken. 32(5). 371–374. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact